GABRIELLA BROGNA: Open Payments
NPI 1386249001 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 26 payments from 8 companies in 2025. Trend: 2023 $431 · 2024 $360 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 4 | $169 |
| Novartis Pharmaceuticals Corporation | 4 | $133 |
| Celgene Corporation | 5 | $130 |
| Alexion Pharmaceuticals, Inc. | 4 | $78 |
| Biogen, Inc. | 3 | $71 |
| TG Therapeutics, Inc. | 2 | $51 |
| Genentech USA, Inc. | 2 | $47 |
| Cycle Pharmaceuticals Inc | 2 | $47 |
Products named: KESIMPTA, ZEPOSIA, ULTOMIRIS, BRIUMVI, TYSABRI, Ocrevus Zunovo, Tascenso ODT, SKYCLARYS.
Industry payments across NY — which companies pay providers there.
